摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(2-甲氧基苯基)庚烷-1-醇 | 104941-44-8

中文名称
1-(2-甲氧基苯基)庚烷-1-醇
中文别名
——
英文名称
1-(2-methoxyphenyl)heptan-1-ol
英文别名
——
1-(2-甲氧基苯基)庚烷-1-醇化学式
CAS
104941-44-8
化学式
C14H22O2
mdl
——
分子量
222.327
InChiKey
XFYAOONERYSOBT-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.9
  • 重原子数:
    16
  • 可旋转键数:
    7
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.57
  • 拓扑面积:
    29.5
  • 氢给体数:
    1
  • 氢受体数:
    2

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    1-(2-甲氧基苯基)庚烷-1-醇三乙基硅烷三溴化硼碳酸氢钠三氟乙酸 作用下, 以 二氯甲烷 为溶剂, 反应 1.0h, 生成 2-庚基苯酚
    参考文献:
    名称:
    4,4′-Unsymmetrically substituted 3,3′-biphenyl alpha helical proteomimetics as potential coactivator binding inhibitors
    摘要:
    A series of unsymmetrically substituted biphenyl compounds was designed as alpha helical proteomimetics with the aim of inhibiting the binding of coactivator proteins to the nuclear hormone receptor coactivator binding domain. These compounds were synthesized in good overall yields in seven steps starting from 2-bromoanisole. The final products were evaluated using cotransfection reporter gene assays and mammalian two-hybrid competitive inhibition assays to demonstrate their effectiveness as competitive binding inhibitors. The results from this study indicate that these proteomimetics possess the ability to inhibit coactivator-receptor interactions, but via a mixed mode of inhibition. (C) 2013 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2013.10.051
  • 作为产物:
    描述:
    庚醛2-溴苯甲醚magnesium 作用下, 以 四氢呋喃 为溶剂, 反应 6.17h, 以85%的产率得到1-(2-甲氧基苯基)庚烷-1-醇
    参考文献:
    名称:
    4,4′-Unsymmetrically substituted 3,3′-biphenyl alpha helical proteomimetics as potential coactivator binding inhibitors
    摘要:
    A series of unsymmetrically substituted biphenyl compounds was designed as alpha helical proteomimetics with the aim of inhibiting the binding of coactivator proteins to the nuclear hormone receptor coactivator binding domain. These compounds were synthesized in good overall yields in seven steps starting from 2-bromoanisole. The final products were evaluated using cotransfection reporter gene assays and mammalian two-hybrid competitive inhibition assays to demonstrate their effectiveness as competitive binding inhibitors. The results from this study indicate that these proteomimetics possess the ability to inhibit coactivator-receptor interactions, but via a mixed mode of inhibition. (C) 2013 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2013.10.051
点击查看最新优质反应信息

文献信息

  • OSMAN, A. M.;BADR, M. Z. A.;EL-NAGGAR, G. M.;ALY, M. M.;FAHMY, A. M., EGYPT. J. CHEM., 1984, 27, N 1, 1-9
    作者:OSMAN, A. M.、BADR, M. Z. A.、EL-NAGGAR, G. M.、ALY, M. M.、FAHMY, A. M.
    DOI:——
    日期:——
  • 4,4′-Unsymmetrically substituted 3,3′-biphenyl alpha helical proteomimetics as potential coactivator binding inhibitors
    作者:Patrick T. Weiser、Ching-Yi Chang、Donald P. McDonnell、Robert N. Hanson
    DOI:10.1016/j.bmc.2013.10.051
    日期:2014.1
    A series of unsymmetrically substituted biphenyl compounds was designed as alpha helical proteomimetics with the aim of inhibiting the binding of coactivator proteins to the nuclear hormone receptor coactivator binding domain. These compounds were synthesized in good overall yields in seven steps starting from 2-bromoanisole. The final products were evaluated using cotransfection reporter gene assays and mammalian two-hybrid competitive inhibition assays to demonstrate their effectiveness as competitive binding inhibitors. The results from this study indicate that these proteomimetics possess the ability to inhibit coactivator-receptor interactions, but via a mixed mode of inhibition. (C) 2013 Elsevier Ltd. All rights reserved.
查看更多